News
Asahi Kasei Bioprocess Featured in GEN: Julie Kozaili Discusses the Growing Role of Intensified Bioprocessing
Jul 22, 2026
We are pleased to share that Julie Kozaili, PhD, Principal Scientist at Asahi Kasei Bioprocess, was recently featured in an article published by GEN (Genetic Engineering & Biotechnology News), discussing the growing adoption and impact of intensified bioprocessing in modern biomanufacturing.
The article,"Bioprocessing at Full Throttle," explores how intensified bioprocessing is helping biopharmaceutical manufacturers improve productivity, flexibility, and manufacturing efficiency through innovations such as high-cell-density cultures, process integration, and continuous processing. Julie shares her perspective on how these approaches are reshaping biologics manufacturing and enabling organizations to increase output without expanding facility footprints.
Asahi Kasei's Contribution to Intensified Bioprocessing
As intensified bioprocessing continues to gain momentum, Asahi Kasei Bioprocess supports manufacturers through technologies designed to enhance both upstream and downstream operations.
Upstream Processing
BioOptimal™ Microfilters are engineered for cell clarification in intensified upstream processes, including perfusion cell culture. Leveraging Asahi Kasei's hollow-fiber membrane technology, BioOptimal microfilters provide high product sieving, reduced fouling, and scalable performance from process development through GMP manufacturing. They are compatible with a variety of intensified cell culture strategies, including TFF, rTFF, ATF, and N-1 perfusion applications.
Downstream Processing
For downstream operations, Planova™ virus removal filters support robust viral clearance strategies that can be integrated into modern manufacturing platforms, including intensified and continuous processing approaches.
At Asahi Kasei Bioprocess, we remain committed to helping biopharmaceutical manufacturers advance intensified bioprocessing through innovative technologies and application expertise across the entire manufacturing workflow.
Read the full article Bioprocessing at Full Throttle
The article,"Bioprocessing at Full Throttle," explores how intensified bioprocessing is helping biopharmaceutical manufacturers improve productivity, flexibility, and manufacturing efficiency through innovations such as high-cell-density cultures, process integration, and continuous processing. Julie shares her perspective on how these approaches are reshaping biologics manufacturing and enabling organizations to increase output without expanding facility footprints.
Asahi Kasei's Contribution to Intensified Bioprocessing
As intensified bioprocessing continues to gain momentum, Asahi Kasei Bioprocess supports manufacturers through technologies designed to enhance both upstream and downstream operations.
Upstream Processing
BioOptimal™ Microfilters are engineered for cell clarification in intensified upstream processes, including perfusion cell culture. Leveraging Asahi Kasei's hollow-fiber membrane technology, BioOptimal microfilters provide high product sieving, reduced fouling, and scalable performance from process development through GMP manufacturing. They are compatible with a variety of intensified cell culture strategies, including TFF, rTFF, ATF, and N-1 perfusion applications.
Downstream Processing
For downstream operations, Planova™ virus removal filters support robust viral clearance strategies that can be integrated into modern manufacturing platforms, including intensified and continuous processing approaches.
At Asahi Kasei Bioprocess, we remain committed to helping biopharmaceutical manufacturers advance intensified bioprocessing through innovative technologies and application expertise across the entire manufacturing workflow.
Read the full article Bioprocessing at Full Throttle
